Marc Bernard

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 13, 2025

Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).

Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).

Journal: Haematologica

Published: December 13, 2024

Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.

Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.

Journal: Journal of hematology & oncology

Published: October 03, 2023

Patients Participating in Nasogastric Tube Insertion through Hypnoanalgesia during High-dose Chemotherapy-induced Aplasia.

Patients Participating in Nasogastric Tube Insertion through Hypnoanalgesia during High-dose Chemotherapy-induced Aplasia.

Journal: The International journal of clinical and experimental hypnosis

Published: January 09, 2023

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.

Journal: Lancet (London, England)

Published: August 30, 2022

Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France.

Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France.

Journal: Leukemia research

Published: December 10, 2021

Hepato-splenic candidiasis confirmed following splenectomy: a case report.

Hepato-splenic candidiasis confirmed following splenectomy: a case report.

Journal: Le infezioni in medicina

Published: September 16, 2021

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.

Journal: European journal of haematology

Published: December 18, 2020

Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.

Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.

Journal: European journal of haematology

Published: December 07, 2020

Heparin-induced thrombocytopenia leading to a diagnosis of essential thrombocythemia.

Heparin-induced thrombocytopenia leading to a diagnosis of essential thrombocythemia.

Journal: International journal of laboratory hematology

Published: November 25, 2020

Acute Care of Older Patients with COVID-19: Clinical Characteristics and Outcomes.

Acute Care of Older Patients with COVID-19: Clinical Characteristics and Outcomes.

Journal: Geriatrics (Basel, Switzerland)

Published: August 19, 2020

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study.

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study.

Journal: Leukemia

Published: April 27, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026